185 related articles for article (PubMed ID: 11165575)
1. Cost-effectiveness of elective cesarean delivery in human immunodeficiency virus-infected women(1).
Chen KT; Sell RL; Tuomala RE
Obstet Gynecol; 2001 Feb; 97(2):161-8. PubMed ID: 11165575
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of cesarean section delivery to prevent mother-to-child transmission of HIV-1.
Halpern MT; Read JS; Ganoczy DA; Harris DR
AIDS; 2000 Apr; 14(6):691-700. PubMed ID: 10807192
[TBL] [Abstract][Full Text] [Related]
3. The cost-effectiveness of elective Cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy.
Mrus JM; Goldie SJ; Weinstein MC; Tsevat J
AIDS; 2000 Nov; 14(16):2543-52. PubMed ID: 11101066
[TBL] [Abstract][Full Text] [Related]
4. Point-of-care HIV viral load in pregnant women without prenatal care: a cost-effectiveness analysis.
Avram CM; Greiner KS; Tilden E; Caughey AB
Am J Obstet Gynecol; 2019 Sep; 221(3):265.e1-265.e9. PubMed ID: 31229430
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of elective Cesarean delivery to prevent hepatitis C transmission in HIV-coinfected women.
Schackman BR; Oneda K; Goldie SJ
AIDS; 2004 Sep; 18(13):1827-34. PubMed ID: 15316344
[TBL] [Abstract][Full Text] [Related]
7. Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort.
Mandelbrot L; Le Chenadec J; Berrebi A; Bongain A; Bénifla JL; Delfraissy JF; Blanche S; Mayaux MJ
JAMA; 1998 Jul; 280(1):55-60. PubMed ID: 9660364
[TBL] [Abstract][Full Text] [Related]
8. Preventing perinatal transmission of HIV--costs and effectiveness of a recommended intervention.
Gorsky RD; Farnham PG; Straus WL; Caldwell B; Holtgrave DR; Simonds RJ; Rogers MF; Guinan ME
Public Health Rep; 1996; 111(4):335-41. PubMed ID: 8711101
[TBL] [Abstract][Full Text] [Related]
9. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
Mofenson LM;
MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
[TBL] [Abstract][Full Text] [Related]
10. Elective cesarean delivery to prevent perinatal transmission of hepatitis C virus: a cost-effectiveness analysis.
Plunkett BA; Grobman WA
Am J Obstet Gynecol; 2004 Sep; 191(3):998-1003. PubMed ID: 15467579
[TBL] [Abstract][Full Text] [Related]
11. A "bloodless cesarean section" and perinatal transmission of the human immunodeficiency virus.
Towers CV; Deveikis A; Asrat T; Major C; Nageotte MP
Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):708-14. PubMed ID: 9757976
[TBL] [Abstract][Full Text] [Related]
12. Incremental cost-effectiveness of two zidovudine regimens to prevent perinatal HIV transmission in the United States.
Pinkerton SD; Holtgrave DR; Layde PM
Prev Med; 2000 Jan; 30(1):64-9. PubMed ID: 10642461
[TBL] [Abstract][Full Text] [Related]
13. Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group.
Kind C; Rudin C; Siegrist CA; Wyler CA; Biedermann K; Lauper U; Irion O; Schüpbach J; Nadal D
AIDS; 1998 Jan; 12(2):205-10. PubMed ID: 9468370
[TBL] [Abstract][Full Text] [Related]
14. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
[TBL] [Abstract][Full Text] [Related]
15. Cesarean section delivery to prevent vertical transmission of human immunodeficiency virus type 1. Associated risks and other considerations.
Read JS
Ann N Y Acad Sci; 2000 Nov; 918():115-21. PubMed ID: 11131694
[TBL] [Abstract][Full Text] [Related]
16. Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency virus in unregistered parturients: a cost-effectiveness analysis.
Stringer JS; Rouse DJ
Obstet Gynecol; 1999 Jul; 94(1):34-40. PubMed ID: 10389714
[TBL] [Abstract][Full Text] [Related]
17. Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010.
Briand N; Jasseron C; Sibiude J; Azria E; Pollet J; Hammou Y; Warszawski J; Mandelbrot L
Am J Obstet Gynecol; 2013 Oct; 209(4):335.e1-335.e12. PubMed ID: 23791563
[TBL] [Abstract][Full Text] [Related]
18. Cesarean delivery for HIV-infected women: recommendations and controversies.
Jamieson DJ; Read JS; Kourtis AP; Durant TM; Lampe MA; Dominguez KL
Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S96-100. PubMed ID: 17825656
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of cesarean delivery for prevention of mother-to-child transmission of HIV-1.
Read JS; Newell MK
Cochrane Database Syst Rev; 2005 Oct; (4):CD005479. PubMed ID: 16235405
[TBL] [Abstract][Full Text] [Related]
20. Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina.
Fiscus SA; Adimora AA; Funk ML; Schoenbach VJ; Tristram D; Lim W; McKinney R; Rupar D; Woods C; Wilfert C
Pediatr Infect Dis J; 2002 Jul; 21(7):664-8. PubMed ID: 12237600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
